Abstract
Introduction
Plaque calcification is a biomarker of early atherosclerosis [1] and correlates with complication, severity and plaque stability [2, 3] . [4, 5] and also of osteochondral differentiation by other cells in the artery, including adventitial myofibroblasts [6] , stem cells and pericytes [7] [8] [9] . The differentiation to 'bone-forming' chondrocyte-or osteoblast-like cells is accompanied by the expression of tissue-nonspecific alkaline phosphatase, increased fibrillar collagen type I expression [10] and certain matrix proteins, e.g. osteopontin (OPN) , osteocalcin (OC), collagen type II and type X [11] [12] [13] [14, 15] . Specifically, it was shown that SMCs normally express inhibitors of mineralization, such as inorganic pyrophosphate (PPi) and matrix gla protein (Mgp), respectively, and that lack of these molecules leads to spontaneous vascular calcification and increased mortality [16, 17] .
Whereas arterial calcification in aging, diabetes mellitus and end-stage renal disease is primarily confined to the medial layer, calcification in atherosclerosis occurs in the intimal plaque. Both intima and media calcification appear to be mediated by ectopic cartilage and bone formation, a consequence of the now welldocumented transdifferentiation potential of vascular smooth muscle cells (SMCs)

. Recent studies in human beings and animal models have demonstrated that (as in mineralizing bone) arterial calcification is inhibited by physiological function of resident cells (including SMCs and endothelial cells)
One of these inhibitors is the nucleotide pyrophosphatase/ phosphodiesterase (NPP) family member NPP1, because severe inborn deficiency of NPP1 is associated with calcification of arteries in mice and human beings [18, 19] .
NPP1 is a major generator of extracellular PPi in cartilage and a variety of other tissues, including heart, kidney, liver, pancreas and skeletal muscle [20] . PPi potently inhibits hydroxyapatite crystal deposition and growth and regulates chondrogenesis, collagen I expression and synthesis [21] and other cell differentiation processes [22] . These include promotion of the expression of OPN by PPi [19, 23] , which in turn promotes atherogenesis via recruitment of monocyte macrophages, and also inhibits arterial calcification by effects that include suppression of hydroxyapatite crystal growth [24] .
The physiological role of NPP1-mediated PPi generation in tissue calcification has come to light recently. In human beings, inactivating homozygous or inactivating compound heterozygous mutations of ENPP1 are associated with generalized arterial calcification of infancy (GACI), a frequently lethal form of disseminated arterial media calcification and myointimal proliferation [25] . In Enpp1 knockout mice, hydroxyapatite crystals are found in the aortic medial layer at the level of the internal elastic lamina [18] . These mice additionally develop abnormal calcification of periarticular tissues [23] . A similar phenotype was found in the ttw/ttw mouse, harbouring a homozygous truncation mutation in the Enpp1 gene [26, 27] .
The role of NPP1 in atherogenesis and intimal calcification is unknown. Previous studies have shown that the lack of Npp1 leads to decreased expression of Opn in osteoclasts [23] . Opn is a known chemoattractant for macrophages, the most prominent cell type in atherosclerotic lesions [28] 
Materials and methods
Mice
RT-PCR analyses
Opn expression is decreased in Npp1-deficient ApoE null atherosclerotic lesions
Opn was mainly present in areas of the plaque containing macrophages (Fig. 2) (Fig. 3D-F Fig. 5D and Table 3 ).
For serum cholesterol and triglycerides samples, blood was obtained by retro-orbital venipuncture from mice with high-fat/high-cholesterol diet (high-fat diet) and from mice fed with normal chow diet (control diet). Data are presented as mean Ϯ S.D. for n ϭ 4-
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high-fat/high-cholesterol diet. Haematoxylin and eosin stained sections (A-C) of the whole aortic arch. Von Kossa staining for calcifications (brown, arrows) of atherosclerostic lesions (D-F) and the aortic wall (G-I).
Conclusions
Based on the results of our current study and previous work [29] , we propose a novel model for modulation of NPP1 expression and the role of NPP1 in promotion of atherogenesis and suppression of intimal plaque calcification (Fig. 6 ). NPP1 generates PPi and thereby promotes OPN expression [23, 36] , which is a known chemoattractant for monocyte macrophages [28] . It is known, that NPP1 is up-regulated by transforming growth factor (TGF)-␤ [41] and down-regulated by interleukin (IL)-1␤ [42] . During atherosclerotic lesion progression, the expression of proinflammatory cytokines including IL-1␤ is increased [43, 44] , whereas TGF-␤ responsiveness is suppressed [45] [45] and increased inflammation including IL-1␤ expression [43, 44] 
